Global Pancreatic Cancer Therapeutics Market (2019-2023): Expected to Exceed a CAGR of 8% - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 23, 2019--The “Global Pancreatic Cancer Therapeutics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.
The pancreatic cancer therapeutics market will register a CAGR of more than 8% by 2023.
Availability of improved diagnostic modalities to drive growth in the market
To combat the shortcomings in the prognosis of pancreatic cancer, advanced diagnostic aids based on the principles of complementary DNA (cDNA) fingerprinting, PCR, and DNA microarray, and molecular profiling are being developed.
Robust pipeline and new drug approvals
The pipeline for the treatment of pancreatic cancer includes novel therapeutic approaches, including vaccines, gene therapy, stem cell therapy, and targeted therapy products.
High cost of treatments
Pancreatic cancer requires long term treatment, which increases the treatment cost and the economic burden on patients.
Key PlayersEli Lilly F. Hoffmann-La Roche Novartis Pfizer Shire
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: PIPELINE ANALYSIS
PART 05: MARKET SIZING
PART 06: FIVE FORCES ANALYSIS
PART 07: MARKET SEGMENTATION BY PRODUCTComparison by product Targeted therapy - Market size and forecast 2018-2023 Chemotherapy - Market size and forecast 2018-2023 Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: MARKET SEGMENTATION BY TYPEExocrine pancreatic cancer Endocrine pancreatic cancer
PART 10: GEOGRAPHIC LANDSCAPEGeographic comparison Americas - Market size and forecast 2018-2023 EMEA - Market size and forecast 2018-2023 APAC - Market size and forecast 2018-2023 Key leading countries Market opportunity
PART 11: DRIVERS AND CHALLENGES
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
PART 14: VENDOR ANALYSISVendors covered Vendor classification Market positioning of vendors Eli Lilly F. Hoffmann-La Roche Novartis Pfizer Shire
For more information about this report visit https://www.researchandmarkets.com/research/6s4d5h/global_pancreatic?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190123005456/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Pancreatic Cancer Drugs
INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 01/23/2019 08:27 AM/DISC: 01/23/2019 08:27 AM